Computer-Assisted Stop-Smoking Program in Helping Doctors Counsel Patients Who Smoke Cigarettes
Clinical Testing of a Decision Support System for Tobacco Use Treatment
RATIONALE: A computer-assisted stop-smoking program may help doctors counsel patients who smoke and may help increase the number of patients who stop smoking.
PURPOSE: This phase II trial is studying how well a computer-assisted stop-smoking program works in helping doctors counsel patients who smoke cigarettes.
調査の概要
状態
条件
詳細な説明
OBJECTIVES:
- Test the hypothesis that the clinical decision support system will improve the rate at which physicians assist their patients with smoking cessation by providing information and recommendations on smoking cessation resources.
- Assess whether exposure to information and recommendations facilitated by the smoking cessation-personal digital assistant (SC-PDA) will increase the rate at which patients make at least 1 attempt to quit smoking in the month following the physician visit.
- Assess whether exposure to information and recommendations facilitated by the SC-PDA will increase the reported use of counseling and pharmacotherapy during those attempts over that observed with a smoking status identification system alone.
- Evaluate the acceptance of the SC-PDA into the workflow of ambulatory care clinics.
OUTLINE: In weeks 1-12, physicians have access to a smoking status identification system (SSID) that reminds the physician the smoking status of the patient they are evaluating. In weeks 6-12, physicians have access to a computerized smoking cessation clinical decision support system using a hand-held personal digital assistant (SC-PDA) that they can use in the exam room with their patients who smoke. The SC-PDA system assists physicians in recommending and prescribing approved pharmacotherapy; facilitates referral of patients to local counseling resources; prints a tailored handout for a patient listing specific recommendations, instructions, and cessation resources; and generates the necessary documentation to support billing for this intervention.
Patients who visit their physician in weeks 2-6 or weeks 8-12 complete a survey after their clinic visit and undergo a telephone interview 1 month later. Physicians undergo interviews and focus groups are conducted with clinic staff in weeks 12-16.
研究の種類
入学 (予想される)
段階
- フェーズ2
連絡先と場所
研究場所
-
-
Vermont
-
Burlington、Vermont、アメリカ、05405-0110
- 募集
- Vermont Cancer Center at University of Vermont
-
コンタクト:
- Clinical Trials Office - Vermont Cancer Center at University o
- 電話番号:802-656-2178
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
DISEASE CHARACTERISTICS:
- Current smoker, defined as self-reported smoking most days or every day (patient)
- Seeks care at a participating Fletcher Allen Health Care primary care clinic (patient)
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- Not specified
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:ヘルスサービス研究
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
---|
Physician adherence to the United States Public Health Service's Tobacco Use and Dependence Treatment guideline (USPHS Guideline) as measured by the patient exit survey
|
Patient perception of physician as measured by the patient exit survey and telephone interview
|
Prevalence of smoking and associated variables as measured by the patient exit survey
|
Patient interaction with the smoking cessation-personal digital assistant (SC-PDA) as measured by the patient exit survey and telephone interview
|
Patient report of physician SC-PDA use as measured by the patient exit survey and telephone interview
|
Aggregate data on accessing SC-PDA screens by each physician as measured by the SC-PDA server log
|
Generation of patient handouts as measured by the SC-PDA server log, clinic staff focus groups, and telephone interview
|
Physician self-reported use of SC-PDA as measured by physician interview
|
Physician opinion on perceived value and barriers to use as measured by physician interview
|
Clinic staff opinion on the effect of SC-PDA on clinic workflow as measured by clinic staff focus groups
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Theodore W. Marcy, MD, MPH、University of Vermont
研究記録日
主要日程の研究
研究開始
一次修了 (予想される)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
タバコ使用障害の臨床試験
アンケート管理の臨床試験
-
Fondazione Poliambulanza Istituto Ospedalieroわからない